Henric from Australia

Registered at the short selling broker Capital, 2 minutes ago.

» Try Capital you too
67.7% of retail investor accounts lose money when trading CFDs with Capital.
Don't show again

Baxter International, Inc. (BAX) shares information

Baxter International Inc.

24h Change

1.16 %


Live rate:

Stock data per Monday 8 Aug, 2022

0.68 (+ 1.16%)
US Market is open

Live Stock price in graph for Baxter International Inc. (BAX)

Data updated continously for BAX, showing up to the 500 most recent 100 data points

  • Latest Volume

    1,256,140 (-48.7 %)

  • Volume prev. day


  • Avg. daily volume


  • Market cap


  • P/E ratio


  • Today high

    59.72 USD

  • Today low

    58.47 USD

  • 52 week high

    89.06 USD

  • 52 week low

    57.49 USD

  • YTD Change


Quick links


Latest news about Baxter International Inc.

Below you can find the most recent news posts about Baxter International Inc., primarily from US and UK based news sources.

Baxter International Inc. – Consensus Indicates Potential 25.8% Upside

Monday, 8 August 2022, 14:52:18
Baxter International Inc. found using ticker (BAX) now have 13 analysts covering the stock. The analyst consensus points to a rating of ”Buy”. The target price ranges between 100 and 60 calculating the mean target price we have 72.85. Given that the stocks previous close was at 57.91 this would indicate that there is a potential upside of 25.8%. There is a 50 day moving average of 66.63 and the 200 day MA is 76.95. The market capitalisation for the company is $29,507m. You can visit the company”s website by visiting: https://www.baxter.com [stock_market_widget type=”chart” template=”basic” color=”green” assets=”BAX” range=”6mo” interval=”1d” axes=”true” cursor=”true” api=”yf”] The potential market cap would be $37,119m based on the market concensus. Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug platforms, inhaled anesthesia and critical care products and pharmacy compounding services; parenteral nutrition therapies and related products; biological products and medical devices used in surgical procedures for hemostasis, tissue sealing and adhesion prevention; and continuous renal replacement therapies and other organ support therapies focused in the intensive care unit.
— DirectorsTalk

Global Infusion Pumps and Devices Market Report 2022: Rising Demand for Ambulatory Infusion Pumps, Especially in Home Care Settings Driving Growth – ResearchAndMarkets.com

Monday, 8 August 2022, 11:12:00

— Kwhen Finance

SEVEN EIGHT CAPITAL, LP Buys 2, Sells 3 in 2nd Quarter

Thursday, 4 August 2022, 21:00:21
Related Stocks: RBLX , SWN , NKE , WDAY , BAX ,
— GuruFocus

Thursday Upgrades Downgrades: Advanced Micro Devices, Baxter, Caesars, Electronic Arts, Gilead Sciences, Intel, JetBlue, Marriott, Match, Microchip Technology, Starbucks, Uber Technologies

Thursday, 4 August 2022, 14:56:19
day’s top analyst upgrades and downgrades included Advanced Micro Devices, Baxter International, Caesars Entertainment, Electronic Arts, Exact Sciences, Gilead Sciences, Intel, JetBlue Airways, Marriott International, Match Group, Microchip Technology, Starbucks and Uber Technologies.
— 24/7 Wall street

Baxter International”s Return On Capital Employed Overview

Tuesday, 2 August 2022, 16:04:23
According to Benzinga Pro, during Q2, Baxter International (NYSE: BAX ) earned $255.00 million, a 249.32% increase from the preceding quarter. Baxter International also posted a total of $3.75 billion in sales, a 1.05% increase since Q1. In Q1, Baxter International earned $73.00 million, and total sales reached $3.71 billion. What Is ROCE? Return on Capital Employed is a measure of yearly pre-tax profit relative to capital employed by a business. Changes in earnings and sales indicate shifts in a company”s ROCE. A higher ROCE is generally representative of successful growth of … Full story available on Benzinga.com
— Benzinga

Trading broker recommendation

We recommend that you check out Capital.com as they have a very good selection of stocks available for both going short and long.

Rating: 9.57/10
Minimum deposit: €250 by bank
Description: Capital.com offer a large number of stocks for trading. Register an account today and check if they have BAX available or trade one of the many other CFD stocks they have.
Risk warning: 67.7% of retail investor accounts lose money when trading CFDs with Capital.